In peripheral tissue, altered splicing or aberrant expression of BIN1 has been linked to cancer progression and centronuclear myopathy, and plasma BIN1 levels are associated with ventricular cardiomyopathy (9, 10). Here, BIN1 is linked to centronuclear myopathy.